Skip to content
healthcare.dev

Sucralfate

NDC 65162-062, Sucralfate Oral, suspension, from Amneal Pharmaceuticals LLC.

Product NDC
65162-062
Status
Listed
Labeler
Amneal Pharmaceuticals LLC
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA209356
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/65162-062 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SUCRALFATE1 g/10mL

Pharmacologic classes

Aluminum Complex [EPC]; Organometallic Compounds [CS]

Package NDCNDC-11Package
65162-062-0565162006205420 mL in 1 BOTTLE (65162-062-05)
65162-062-486516200624810 CUP, UNIT-DOSE in 1 TRAY (65162-062-48) / 10 mL in 1 CUP, UNIT-DOSE (65162-062-47)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/4350b771-76a9-4e00-93f0-a18c71288f83
  • NADAC price for package 65162006205

    GET /v1/drugs/nadac/65162006205

Use it

Look up 65162-062 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/65162-062 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 65162-062. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.